Fanconi Anemia Pathway Deficiency Drives Copy Number Variation in Squamous Cell Carcinomas
A. L. H. Webster, M. A. Sanders, K. Patel, R. Dietrich, R. J. Noonan, F. P. Lach, R. R. White, A. Goldfarb, K. Hadi, M. M. Edwards, F. X. Donovan, M. Jung, S. Sridhar, O. Fedrigo, H. Tian, J. Rosiene, T. Heineman, J. A. Kennedy, L. Bean, O. Rosti, R. Tryon, A.-M. Gonzalez, A. Rosenberg, J.-D. Luo, T. Carrol, , P. Campbell
Abstract
Fanconi anemia (FA), a model syndrome of genome instability, is caused by a deficiency in DNA interstrand crosslink (ICL) repair resulting in chromosome breakage1-3. The FA repair pathway comprises at least 22 FANC proteins including BRCA1 and BRCA24-6, and protects against carcinogenic endogenous and exogenous aldehydes7-10. Individuals with FA are hundreds to thousands-fold more likely to develop head and neck (HNSCC), esophageal and anogenital squamous cell carcinomas (SCCs) with a median onset age of 31 years11. The aggressive nature of these tumors and poor patient tolerance of platinum and radiation-based therapy have been associated with short survival in FA11-16. Molecular studies of SCCs from individuals with FA (FA SCCs) have been limited, and it is unclear how they relate to sporadic HNSCCs primarily driven by tobacco and alcohol exposure or human papillomavirus (HPV) infection17. Here, by sequencing FA SCCs, we demonstrate that the primary genomic signature of FA-deficiency is the presence of a high number of structural variants (SVs). SVs are enriched for small deletions, unbalanced translocations, and fold-back inversions that arise in the context of TP53 loss. The SV breakpoints preferentially localize to early replicating regions, common fragile sites, tandem repeats, and SINE elements. SVs are often connected forming complex rearrangements. Resultant genomic instability underlies elevated copy number alteration (CNA) rates of key HNSCC-associated genes, including PIK3CA, MYC, CSMD1, PTPRD, YAP1, MXD4, and EGFR. In contrast to sporadic HNSCC, we find no evidence of HPV infection in FA HNSCC, although positive cases were identified in gynecologic tumors. A murine allograft model of FA pathway-deficient SCC was enriched in SVs, exhibited dramatic tumor growth advantage, more rapid epithelial-to-mesenchymal transition (EMT), and enhanced autonomous inflammatory signaling when compared to an FA pathway-proficient model. In light of the protective role of the FA pathway against SV formation uncovered here, and recent findings of FA pathway insufficiency in the setting of increased formaldehyde load resulting in hematopoietic stem cell failure and carcinogenesis18-20, we propose that high copy-number instability in sporadic HNSCC may result from functional overload of the FA pathway by endogenous and exogenous DNA crosslinking agents. Our work lays the foundation for improved FA patient treatment and demonstrates that FA SCC is a powerful model to study tumorigenesis resulting from DNA crosslinking damage.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Fanconi anemia-isogenic head and neck cancer cell line pairs - a basic and translational science resource
H. T. Nguyen, W. Tang, … R. J. Monnat·bioRxiv·Sep 11, 2022
- Generating new FANCA-deficient HNSCC cell lines by genomic editing recapitulate the cellular phenotypes of Fanconi anemia
R. Errazquin, E. Sieiro, … R. Garcia-Escudero·bioRxiv·Oct 3, 2020
- Development of a mouse model for spontaneous oral squamous cell carcinoma in Fanconi anemia
R. Errazquin, A. Page, … R. Garcia-Escudero·bioRxiv·Jun 5, 2022
- Rare, pathogenic germline variants in Fanconi Anemia genes increase risk for squamous lung cancer
Myvizhi Esai Selvan, Robert J. Klein, Zeynep Hulya Gumus·Clinical Cancer ResearchPeer-reviewed·Nov 13, 2018
- Early diagnosis of oral cancer and lesions in Fanconi anemia patients: a prospective and longitudinal study using saliva and plasma
Ricardo Errazquin, Estela Carrasco, … Ramón García‐Escudero·CancersPeer-reviewed·Mar 21, 2023
- Suppression of non-homologous end joining does not rescue DNA repair defects in Fanconi anemia patient cells
Supawat Thongthip, Brooke A. Conti, … Agata Smogorzewska·Cell CyclePeer-reviewed·Aug 30, 2020